Company: SHPH
Filing Date: 2025-01-24
Form Type: 424B3
Source: 0001493152-25-003508
Chunk: 184

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-01-24
Form: 424B3
Chunk 184
---
 January 2023 Alto Convertible Note, Boustead was granted warrants to purchase 8,909shares of common stock, at an exercise price of $ 18.80per share (Note 5). Effective with the recent reverse split, the exercise price was adjusted to $ 1.93per share, as provided for in the underlying agreement. In addition, Alto was granted warrants to purchase 127,260shares of common stock, at an exercise price of $ 1.93per share, as adjusted (Note 5, 7).

A summary of activity regarding all warrants issued for the nine months ended September 30, 2024 were as follows:

Schedule of Warrants Activity

|                                 |     | Number of 
 warrants  |         |     | Weighted Average 
 Exercise Price   |       |     | Average      
 Life (years) |      |
|:--------------------------------|:----|:----------|--------:|:----|:-----------------|------:|:----|:-------------|-----:|
| Outstanding, December 31, 2023  |     |           | 184,000 |     | $                | 23.20 |     |              | 2.77 |
| Granted                         |     |           |       - |     |                  |     - |     |              |    - |
| Outstanding, September 30, 2024 |     |           | 184,000 |     | $                | 11.54 |     |              | 2.04 |

The intrinsic value of the warrants as of September 30, 2024 is $ 0. All of the outstanding warrants are exercisable as of September 30, 2024.

Equity Incentive Plan

Our 2018 Equity Incentive Plan (the “2018 Plan”) provides for equity incentives to be granted to our employees, executive officers, directors and key advisers and consultants. Equity incentive grants may be made in the form of stock options with an exercise price of not less than the fair market value of the underlying shares as determined pursuant to the 2018 Equity Incentive Plan, restricted stock awards, other stock-based awards, or any combination of the foregoing. The 2018 Equity Incentive Plan is administered by the Company’s compensation committee. We have reserved 3,000,000shares of our common stock for issuance under the 2018 Equity Incentive Plan. As of September 30, 2024, 125